National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Insurance Coverage: Connecticut
    Posted: 12/19/2002    Reviewed: 12/17/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Cover Patient Care Costs in Clinical Trials.


Legislation: Senate Bill 325

Effective: January 2002

What clinical trials are covered?

Clinical trials for treatment, palliation (supportive care), or prevention of cancer approved by one of the following:

  • National Institutes of Health (NIH)
  • National Cancer Institute cooperative group or center
  • U.S. Food and Drug Administration
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs

Who is required to pay?

Private insurers, including individual and group health plans.

Other key criteria:

  • Prevention trials are covered only in Phase III and only if they involve therapeutic intervention.
  • Insurer may require documentation of the likelihood of therapeutic benefit, informed consent, protocol information and test results, and/or a summary of costs involved.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov